Mokadam Nahush A, Melford Ryland E, Maynard Charles, Goss John R, Stewart Douglas, Reisman Mark, Aldea Gabriel S
Division of Cardiothoracic Surgery University of Washington Medical Center, Seattle, Washington 98195, USA.
J Card Surg. 2011 Jan;26(1):1-8. doi: 10.1111/j.1540-8191.2010.01072.x. Epub 2010 Oct 3.
Percutaneous coronary intervention (PCI) is used with increasing frequency in patients with diabetes and multivessel disease. This study investigated evolving revascularization strategies in the State of Washington.
The Clinical Outcomes Assessment Program captures all revascularization in the State of Washington and was used to compare diabetic patients with multivessel disease undergoing first-time revascularization from 1999 to 2007. Categorical variables were compared with the chi-squared test and continuous variables were compared with the student's t-test. Results were risk-adjusted using a logistic regression.
A total of 11,602 patients with diabetes and multivessel disease underwent revascularization from 1999 to 2007 and were nearly equally divided between coronary artery bypass grafting (CABG) (51%) and PCI (49%). Patients undergoing CABG had a higher (p < 0.0001) prevalence of congestive heart failure, cerebrovascular disease, peripheral vascular disease, three-vessel coronary artery disease (CAD), and intraaortic balloon pump insertion, but a lower prevalence of female gender, cardiogenic shock, and emergency procedures. Patients undergoing CABG had more (p < 0.0001) three-vessel CAD and more complete revascularization (3.7 vs. 1.5 lesions treated). Short-term risk-adjusted mortality was equivalent. The prevalence of PCI increased from 34.1% in 1999 to 59.4% in 2007.
PCI is applied with increasing frequency to patients with diabetes mellitus (DM) and multivessel disease. PCI is used most commonly in two-vessel CAD or with acute coronary syndromes with more limited and targeted revascularization. CABG is more commonly applied to extensive disease with more complete revascularization. Both the prevalence and percentage of patients undergoing PCI as primary therapy for multivessel disease with DM is increasing. A multidisciplinary approach may be warranted to ensure optimal outcomes.
经皮冠状动脉介入治疗(PCI)在糖尿病合并多支血管病变患者中的应用频率日益增加。本研究调查了华盛顿州不断演变的血运重建策略。
临床结局评估项目记录了华盛顿州所有的血运重建情况,并用于比较1999年至2007年首次接受血运重建的糖尿病合并多支血管病变患者。分类变量采用卡方检验进行比较,连续变量采用学生t检验进行比较。结果采用逻辑回归进行风险调整。
1999年至2007年,共有11602例糖尿病合并多支血管病变患者接受了血运重建,冠状动脉旁路移植术(CABG)(51%)和PCI(49%)的患者数量几乎相等。接受CABG的患者充血性心力衰竭、脑血管疾病、外周血管疾病、三支血管冠状动脉疾病(CAD)和主动脉内球囊泵置入的患病率较高(p<0.0001),但女性、心源性休克和急诊手术的患病率较低。接受CABG的患者三支血管CAD更多(p<0.0001),血运重建更完全(治疗病变数为3.7个对1.5个)。短期风险调整后的死亡率相当。PCI的患病率从1999年的34.1%上升至2007年的59.4%。
PCI在糖尿病(DM)合并多支血管病变患者中的应用频率越来越高。PCI最常用于双支血管CAD或急性冠状动脉综合征,血运重建更有限且更具针对性。CABG更常用于病变广泛且血运重建更完全的情况。作为DM合并多支血管病变主要治疗方法的PCI的患病率和患者百分比均在增加。可能需要采取多学科方法以确保获得最佳结果。